Entrepreneurial Economics: Bright Ideas from the Dismal Science
You have 119 highlighted passages
You have 113 notes
Last annotated on August 27, 2016
Now, thanks to advances in genetic research, medical practitioners are increasingly able to read your health future from a much more reliable source-your individual genetic code. The correlation between specific genes and some diseases is now well established,Read more at location 699
However, accurate genetic information also brings fear that health insurance could become unaffordable or even unavailableRead more at location 701
And because most individuals are insured through their employer, some people worry that knowledge of genetic traits might lead to employment discrimination.Read more at location 702
Solutions that would maintain access to health insurance have been proposed, but most would almost inevitably lead to antiselection and a disruption of the underwriting process, with potentially dire impact on the solvency of insurers. Read more at location 703
For a small premium cost, genetic insurance would insure against possessing a "bad" gene. Policies would be sold to all individuals before they underwent genetic testing.Read more at location 705
For example, if a woman is found to be carrying BRCAI (the gene related to a higher probability of breast cancer), she would be paid enough to purchase actuarially sound risk premiums.Read more at location 708
We are used to thinking of insuring against sickness; genetic insurance makes it equally possible to insure against a high probability of sickness.Read more at location 709
All the benefits of genetic testing, such as improved treatment and health planning targeted to offset a genetic vulnerability, could be exploitedRead more at location 710
The single ground rule of mandatory purchase would avoid the problem of adverse selection.Read more at location 712
First, most people do not carry serious genetic defects, so the expected gain from concealing a positive result, and thereby cheating an insurer, is small.Read more at location 712
enforcement would be carried out through medical institutions rather than by individuals.Read more at location 713
In the near future, genetic testing is likely to be fully integrated into the medical process.Read more at location 718
Insurance firms, under this proposal, would no longer have an incentive to drop customers with genetic defects.Read more at location 720
Individuals with serious genetic defects would buy their insurance individually (or as part of a special genetic group) rather than through their employer. Employers also would have far fewer incentives to genetically discriminate. Read more at location 722
Genetic insurance also could improve the life insurance market. Life insurance contracts usually are written for much longer terms than health insurance contracts.Read more at location 723
If insurance companies have access to information from genetic tests, many people will want to buy long-term life insurance before the tests are taken. Under this scenario, genetic tests will not cause great difficulties for the life insurance market. But if legislation makes genetic information "private," very serious adverse selection problems could occur.Read more at location 725
Genetic information should be accessible by life insurance companies along with other types of health information.Read more at location 727
It seems likely that everyone who today purchases health insurance also will be able to purchase genetic insurance.Read more at location 733
Genetic insurance cannot raise the total cost of health insurance because today's health insurance already covers the possibility of possessing a defective gene, but it does so implicitly, and given today's technology, inefficiently.Read more at location 734
Separating the genetic and nongenetic health insurance markets cannot raise the total price of health insurance because the same product is being sold.Read more at location 737
In fact, the total price of health insurance will fall under this proposal. Individuals who gain early knowledge of a genetic defect can seek earlier treatment, which is usually cheaper and more effective.Read more at location 738
A 1995 essay by economist J. H. Cochrane, reprinted in this volume, has shown how this idea may be extended so that unexpected changes in the price of health insurance from any source can be insured. Read more at location 741
the essence of the idea is to sell two contracts. The first contract covers health expenses in the next year; the second insures against any changes in expected future health expenses.Read more at location 743